The development of drotrecogin alfa (activated) for the treatment of severe sepsis
Macias, W.L.; Yan, S.B.; Grinnell, B.W.
International Journal of Artificial Organs 27(5): 360-370
2004
ISSN/ISBN: 0391-3988 PMID: 15202813 Document Number: 568894
Document emailed within 1 workday
Related Documents
Maglio, D. 2002: Drotrecogin alfa (activated) for severe sepsis Connecticut Medicine 66(3): 145-150Liang, J.; Streat, S.; Torrance, J.; Sleigh, J.; Freebairn, R.; Ramsay, M. 2003: Drotrecogin alfa (recombinant human activated protein C) in severe sepsis--a New Zealand viewpoint New Zealand Medical Journal 116(1181): U586
Lai, P.S.; Matteau, A.; Iddriss, A.; Hawes, J.C.L.; Ranieri, V.; Thompson, B.T. 2013: An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock Minerva Anestesiologica 79(1): 33-43
Albuali, W.H.; Singh, R.N.; Fraser, D.D.; Scott, L.A.; Kornecki, A. 2005: Drotrecogin alfa (activated) treatment in a neonate with sepsis and multi organ failure Saudi Medical Journal 26(8): 1289-1292
Bartelink, A.K.M. 2006: Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis Nederlands Tijdschrift Voor Geneeskunde 150(7): 352-354
Gøtzsche, P.C. 2013: There is no effect of drotrecogin alfa in severe sepsis Ugeskrift for Laeger 175(13): 903
Banks, S.M.; Gerstenberger, E.; Eichacker, P.Q.; Natanson, C. 2003: Long-term cost effectiveness of drotrecogin alfa (activated): an unanswered question Critical Care Medicine 31(1): 308-309
Taylor, B.; Burns, D.; van de Wal, B.W.; MBewu, T.; Keeton, G.R. 2003: Should health care money in South Africa be spent on drotrecogin alfa? South African Medical Journal 93(7): 500-501
Mahabeer, N.; Zwaal, J. 2005: Activated protein C in a pregnant patient with severe sepsis Hospital Medicine 66(2): 124
Ruangchan, S.; Chusri, S.; Saengsanga, P.; Kiamkan, N.; Phunpairoth, P.; Chayakul, P. 2016: Clinical Outcomes of Community-Acquired Severe Sepsis after Implementation of a Simple Severe Sepsis Fast Track Journal of the Medical Association of Thailand 99(8): 877-885
Brun-Buisson, C.; Doyon, F.; Carlet, J.; Dellamonica, P.; Gouin, F.; Lepoutre, A.; Mercier, J.C.; Offenstadt, G.; Régnier, B. 1995: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274(12): 968-974
González de Dios, J.; Moya Benavent, M.; Herranz Sánchez, Y.; Juste Ruiz, M.; González Montero, R. 1996: The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset Anales Espanoles de Pediatria 44(2): 179-183
McMenamin, L.; Murch, N.; Daniels, R. 2013: Severe sepsis, social media and the #Sepsis 6: 'Tweeting' national innovations Acute Medicine 12(2): 83-88
Aikawa, N. 2011: Revised Surviving Sepsis Campaign Guidelines and therapy for severe sepsis Japanese Journal of Antibiotics 64(1): 37-44
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Fernández, I.; Castellano, G.; Canga, F.; Colina, F.; García, H.; Fuertes, A.; Casis, B.; Martín, A.; Solís, J.A. 1995: A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C Gastroenterologia y Hepatologia 18(2): 66-72
Vetter, G. 1982: Treatment of severe activated arthrosis with Benoxaprofen Münchener Medizinische Wochenschrift 124(32-33): 715-717
Uszyiński, W.; Uszyński, M.ła.; Lisiecki, A. 2005: Novel treatment for severe sepsis: recombinant human protein C (RHAPC) Ginekologia Polska 76(11): 913-920
Aikawa, N.; Fujishima, S. 2004: Understanding the pathogenetic mechanisms of SIRS and sepsis and development of innovative therapies of sepsis Nihon Rinsho. Japanese Journal of Clinical Medicine 62(12): 2173-2176
Chang, T.M.; Espinosa-Meléndez, E.; Francoeur, T.E.; Eade, N.R. 1980: Albumin-collodion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient Pediatrics 65(4): 811-814